Search Results
Mar 28, 2026, 13:30 ET 2.400 metros cuadrados: la pantalla transparente para interiores más grande de Asia brilla en Central World, Tailandia
utiliza la pantalla transparente de la serie UVF de Unilumin (distancia entre píxeles de 10 mm), la cual ofrece un brillo de 8.000 cd/m², una tasa de transparencia superior al 70 % y un diseño ligero de solo 8 kg/m². Mediante una alta frecuencia de actualización de
More news about: Unilumin Group., Ltd.
Mar 28, 2026, 10:42 ET ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026
with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), who have received at least one prior therapy including an anti-CD20 containing regimen." Atara said that "[t]he CRL indicates that the FDA is unable to approve the EBVALLO™ BLA in its present form" because, according
More news about: Faruqi & Faruqi, LLP
Mar 28, 2026, 10:00 ET ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis
NCT071196748) in moderately to severely active ulcerative colitis; and ICONIC-CD (
More news about: Johnson & Johnson
Mar 27, 2026, 21:50 ET 2 400 m² : le plus grand écran transparent d'intérieur d'Asie éblouit le Central World, en Thaïlande
Le projet utilise l'écran transparent de la série UVF d'Unilumin (10 mm de taille de pixel), qui offre une luminosité de 8 000 cd/㎡, un taux de transparence supérieur à 70 % et une conception légère de seulement 8 kg/㎡. Avec un taux de rafraîchissement de 7 680
More news about: Unilumin Group., Ltd.
Mar 27, 2026, 13:57 ET 2,400平方メートル：アジア最大級の屋内透明スクリーンがタイのセントラルワールドで輝きを放つ
このプロジェクトでは、UniluminのUVFシリーズ透明スクリーン（画素ピッチ10mm）を採用しており、8,000cd/㎡の輝度、70%を超える透過率、わずか8kg/㎡の軽量設計を実現しています。7680Hzの高リフレッシュレートと16ビットグレースケール処理により、このディスプレイは、強い環境光の下でも繊細で滑らかな映像と、本物に近い自然な色彩を映し出します。複雑な建築構造に適応するため、Uniluminのチーム
More news about: Unilumin Group., Ltd.
Mar 27, 2026, 12:00 ET 2.400 Quadratmeter: Asiens größter transparenter Indoor-Bildschirm strahlt im Central World in Thailand
Projekt kommt der transparente Bildschirm der UVF-Serie von Unilumin (10 mm Pixelabstand) zum Einsatz, der eine Helligkeit von 8.000 cd/m², eine Transparenz von über 70 % und ein geringes Gewicht von nur 8 kg/m² bietet. Mit einer hohen Bildwiederholfrequenz von 7.680
More news about: Unilumin Group., Ltd.
Mar 27, 2026, 11:46 ET Keymed Biosciences annonce ses résultats annuels pour 2025 et des mises à jour de ses activités
paiement d'étape correspondant, d'un montant total de 45 millions de dollars.CM336 (anticorps bispécifique ciblant la BCMA x CD3) a été cédé sous licence à Ouro Medicines pour le développement mondial (à l'exclusion de la Grande Chine). En mars 2026, Ouro Medicines a annoncé que
More news about: Keymed
Mar 27, 2026, 10:01 ET 2400제곱미터의 아시아 최대 실내 투명 스크린, 태국 센트럴 월드에서 빛나다
이 프로젝트는 유니루민의 UVF 시리즈 투명 스크린(픽셀 피치 10mm)을 적용해 제곱미터당 8000cd, 70% 이상의 투명도, 제곱미터당 8kg의 경량 설계를 구현한다. 7680Hz의 고주사율과 16비트 그레이스케일 처리를 통해 강렬한 주변 광 아래에서도 섬세하고 부드러운 이미지와 사실적이고 자연스러운 색상을 표현한다.복잡한
More news about: Unilumin Group., Ltd.
Mar 27, 2026, 10:00 ET AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
or pill (systemic therapy) when your healthcare provider does not recommend TNF blockers.Adults with moderate to severe Crohn's disease (CD) when 1 or more medicines called TNF blockers have been used and did not work well or could not be tolerated, or after taking a different injection
More news about: AbbVie
Mar 26, 2026, 23:58 ET 2,400 sqm: Asia's Largest Indoor Transparent Screen Shines at Central World, Thailand
The project employs Unilumin's UVF series transparent screen (10 mm pixel pitch), which delivers a brightness of 8,000 cd/㎡, a transparency rate exceeding 70%, and a lightweight design of only 8 kg/㎡. With a 7680Hz high refresh rate and 16-bit grayscale
More news about: Unilumin Group., Ltd.
Mar 26, 2026, 23:44 ET 2,400 sqm: Asia's Largest Indoor Transparent Screen Shines at Central World, Thailand
The project employs Unilumin's UVF series transparent screen (10 mm pixel pitch), which delivers a brightness of 8,000 cd/㎡, a transparency rate exceeding 70%, and a lightweight design of only 8 kg/㎡. With a 7680Hz high refresh rate and 16-bit grayscale
More news about: Unilumin Group., Ltd.
Mar 26, 2026, 15:11 ET Keymed Biosciences gibt die Ergebnisse für das Geschäftsjahr 2025 und aktuelle Geschäftszahlen bekannt
auslöste. Anfang März 2026 erhielt KYM Biosciences Inc. die entsprechende Meilensteinzahlung in Höhe von 45 Mio. USD.CM336 (BCMA x CD3 bispezifischer Antikörper) wurde an Ouro Medicines für die weltweite Entwicklung (mit Ausnahme der Region Greater China) auslizenziert. Im März 2026
More news about: Keymed
Mar 26, 2026, 15:08 ET Keymed Biosciences Announces 2025 Annual Results and Business Updates
el pago por hito correspondiente, que ascendió a 45 millones de dólares estadounidenses.CM336 (BCMA x anticuerpo biespecífico CD3) fue licenciado a Ouro Medicines para su desarrollo global (excluyendo la Gran China). En marzo de 2026, Ouro Medicines anunció que Gilead Sciences adquiriría
More news about: Keymed
Mar 26, 2026, 11:11 ET Gaming Market Poised to Reach USD 649.51 Billion by 2032, Exclusive Report by Maximize Market Research
Take-Two Interactive Software11. Valve Corporation12. Epic Games13. Square Enix Holdings Co., Ltd.14. Capcom Co., Ltd.15. CD Projekt S.A.16. Bandai Namco Entertainment Inc.17. Krafton, Inc.18. Sega Enterprises, Inc.19. Apple, Inc.20. The Walt
More news about: Maximize Market Research Pvt. Ltd.
Mar 26, 2026, 10:00 ET Eurofins Viracor Launches ExPeCT™ anti-CD19 (obe-cel) CAR T-Cell Assay to Advance Proactive Monitoring in Next-Generation Immunotherapy
March 26, 2026 /PRNewswire/ -- Eurofins Viracor, a leader in advanced clinical diagnostics, today announced the launch of the ExPeCT™ anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with validated precision
More news about: Viracor Eurofins
Mar 26, 2026, 09:54 ET Keymed Biosciences Announces 2025 Annual Results and Business Updates
the achievement of relevant milestones as well as the shareholders agreement amongst the Ouro Medicines shareholders.CM355 (CD20 x CD3 bispecific antibody) : In January 2025, the company entered into a license agreement with Prolium, granting exclusive rights for global development
More news about: Keymed
Mar 26, 2026, 09:54 ET Keymed Biosciences Announces 2025 Annual Results and Business Updates
payment. In early March 2026, KYM Biosciences Inc. received the relevant milestone payment totaling US$45 million.CM336 (BCMA x CD3 bispecific antibody) was out-licensed to Ouro Medicines for global development (excluding Greater China). In March 2026, Ouro Medicines announced that
More news about: Keymed
Mar 26, 2026, 08:59 ET Point Wild Releases Free LiteLLM Vulnerability Scanner Within 24 Hours of Supply Chain Attack
noise."wtmp enables developers to quickly scan third-party packages for malicious behavior, including credential harvesting, data exfiltration, obfuscated code, and CI/CD tampering. Unlike traditional tools that rely on known CVEs, this tool uses behavioral analysis and AI-powered classification to detect zero-day supply
More news about: Point Wild
Mar 25, 2026, 10:18 ET XtalPi Holdings Announces Full Year 2025 Annual Results
reprogramming platform to deliver clinical breakthroughs across key disease areas. During the Reporting Period, Leman Biotech's metabolicallyenhanced CD19 CAR-T therapy achieved 100% complete remission in dozens of patients at ultra-low doses in investigator-initiated trials (IITs) for relapsed/refractory
More news about: XtalPi Inc.
Mar 25, 2026, 10:11 ET 晶泰控股發布 2025 年年度業績報告
已完成臨床前研究，即將向中美提交 IND，並入選 2026 年美國癌症研究協會（AACR）年會報告。本集團與希格生科深度合作，為其管線研發提供核心技術賦能，共享企業發展與管線價值成長紅利。賦能萊芒生物AI+代謝重編程技術平台，在多個重大疾病領域取得系列臨床突破。報告期內，其代謝增強型 CD19 CAR-T 在復發/難治性淋巴瘤、白血病及中重度 SLE 的 IIT 研究中以極低劑量實現數十例患者 100% 完全緩解，並在 2026 年 3 月獲得 FDA 針對相關適應症的 IND 批件。與此同時，META 10-TILs 及多條實體瘤 CAR-T 管線已進入 IIT 臨床階段，中美多項申報同步推進。市場研究機構預計，到
More news about: 晶泰科技
Mar 25, 2026, 07:57 ET Kingsoft Cloud Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results
https://register-conf.media-server.com/register/BI62cd2e3d362448ba8a49e0d8c7304f2c. Once preregistration has been completed, participants will receive dial-in numbers, direct event passcode,
More news about: Kingsoft Cloud Holdings Limited
Mar 25, 2026, 06:00 ET HanchorBio Advances Toward TWSE Innovation Board Listing to Accelerate Global Clinical Development, Platform Expansion, and International Partnering
checkpoint program, is currently in clinical development for solid tumors and has advanced into Phase 1b/2 studies. The program is designed to target the CD47-SIRPα axis while maintaining a differentiated hematologic profile. In June 2025, HanchorBio entered into its first regional licensing agreement for
More news about: HanchorBio Inc.
Mar 24, 2026, 22:40 ET Akeso Advances "IO 2.0 + ADC 2.0" Strategy with Phase II Initiation of Novel ADCs Combined with Ivonescimab and Cadonilimab
antibodies, cadonilimab (PD-1/CTLA-4) and ivonescimab (PD-1/VEGF), as well as other proprietary high-potential anti-tumor assets, including AK117 (anti-CD47 monoclonal antibody) and AK109 (anti-VEGF monoclonal antibody), across a spectrum of advanced solid tumors. This milestone marks a strategic acceleration
More news about: Akeso, Inc.
Mar 24, 2026, 10:26 ET MSI presenteert cloud-, AI- en enterprise-serverplatforms op CloudFest 2026
CD270-S3071-X4 is een 2U 4-node-platform dat is ontworpen voor cloudimplementaties met hoge dichtheid. Elke node ondersteunt één Intel Xeon 6-processor (tot
More news about: Micro-Star INT'L CO., LTD.
Mar 24, 2026, 09:17 ET Belay Diagnostics Reports 82% Clinical Impact Rate for Summit™ and Vantage™ in CNS Lymphoma Study
here.The most commonly detected alterations in this cohort were MYD88, a hallmark of CNS lymphoma, followed by TP53 and CD79B, demonstrating that Summit can identify alterations critical to CNS lymphoma diagnosis. Aneuploidy findings were also clinically significant: several
More news about: Belay Diagnostics